On Wednesday, Verve Therapeutics Inc (VERV) stock saw a decline, ending the day at $5.54 which represents a decrease of $-0.15 or -2.64% from the prior close of $5.69. The stock opened at $5.67 and ...
After outstanding results, we’re raising our fair value estimate of ServiceNow’s stock.
Political parties that are challenging Georgian Dream in the October 26 elections say the scare-mongering tactics are meant ...
Eighteen months after its rescue takeover of rival Credit Suisse, UBS Group AG Chief Executive Officer Sergio Ermotti said ...
London Stock Exchange Group said on Thursday that its income rose a better-than-expected 9.5% in the third quarter after ...
The Swiss Bankers Association on Thursday criticised government plans for tougher capital requirements on UBS following the ...
LSEG's total income, excluding recoveries, came in at 2.12 billion pounds ($2.74 billion) in the three months to September 30 ...
Eighteen months after its rescue takeover of rival Credit Suisse, UBS Group AG Chief Executive Officer Sergio Ermotti said ...
Seaport Research Partners has recently raised Dover Corp (DOV) stock to Buy rating, as announced on February 5, 2024, according to Finviz. Earlier, on December 13, 2022, Credit Suisse had initiated ...
Top financial regulators around the globe are voicing concern about private credit valuations, whether lenders are hiding ...
Last year's crash of Credit Suisse has shaken the confidence of wealthy clients from Europe and the Middle East, Deloitte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback